FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) met in Silver Spring, Maryland, on March 3, 2022, to select the influenza viruses for the composition of the influenza vaccine for the 2023-2024 U.S. influenza season.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/VFgPoKB
No comments:
Post a Comment